Abstract
This review summarizes the international experience of pneumococcal immunization of patients with juvenile idiopathic arthritis (JIA). The high efficiency and safety of pneumococcal vaccines in children with JIA is shown. Numerous studies have demonstrated an adequate immune response after vaccination even during therapy with immunosuppressive and genetically engineered biological agents drugs. Prevention of the pneumococcal infection helps avoid the development of pneumonia in patients with JIA.
Highlights
This review summarizes the international experience of pneumococcal immunization of patients with juvenile idiopathic arthritis (JIA)
Prevention of the pneumococcal infection helps avoid the development of pneumonia in patients with JIA
Schiff M, Kaell A, Tay L, et al Response to pneumococcal tions for prevention of invasive pneumococcal disease among vaccine in rheumatoid arthritis patients with an inadequate response adults using the 23-valent pneumococcal polysaccharide vac- to anti-TNF therapy treated with abatacept in the ARRIVE trial
Summary
Вакцинация пациентов с ювенильным идиопатическим артритом против пневмококка: обзор международного опыта. 24 В обзоре обобщен международный опыт иммунизации пациентов с ювенильным идиопатическим артритом (ЮИА) против пневмококка. Ключевые слова: дети, ювенильный идиопатический артрит, вакцинация, пневмококковая инфекция, профилактика, безопасность. В. Вакцинация пациентов с ювенильным идиопатическим артритом против пневмококка. This review summarizes the international experience of pneumococcal immunization of patients with juvenile idiopathic arthritis (JIA). (For citation: Soloshenko Margarita А., Alekseeva Ekaterina I., Bzarova Tatiana М., Isaeva Kseniya B., Denisova Rina V., Lomakina Olga L., Kaschenko Elena М., Karaseva Anna V. Pneumococcal Vaccination of Patients with Juvenile Idiopathic Arthritis: Review of International Experience.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have